OKLO vs. MBX
OKLO (Oklo Inc.) and MBX (MBX Biosciences, Inc) are both stocks. OKLO operates in Utilities - Independent Power Producers (Utilities), while MBX operates in Biotechnology (Healthcare). Over the past year, OKLO returned 17.20% vs 155.06% for MBX. At a 0.15 correlation, their price movements are largely independent.
Performance
OKLO vs. MBX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, OKLO achieves a -17.87% return, which is significantly lower than MBX's -8.05% return.
OKLO
- 1D
- 1.46%
- 1M
- -18.71%
- YTD
- -17.87%
- 6M
- -43.66%
- 1Y
- 17.20%
- 3Y*
- 77.50%
- 5Y*
- —
- 10Y*
- —
MBX
- 1D
- -4.23%
- 1M
- -29.21%
- YTD
- -8.05%
- 6M
- -7.61%
- 1Y
- 155.06%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
OKLO vs. MBX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
OKLO Oklo Inc. | -17.87% | 238.01% | 236.45% |
MBX MBX Biosciences, Inc | -8.05% | 71.13% | -22.07% |
Correlation
The correlation between OKLO and MBX is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Sep 16, 2024 | 0.15 |
Fundamentals
OKLO:
$10.04B
MBX:
$1.35B
OKLO:
-$0.85
MBX:
-$2.30
OKLO:
3.80
MBX:
3.09
OKLO:
$0.00
MBX:
$0.00
OKLO:
-$149.00K
MBX:
-$160.00K
OKLO:
-$172.42M
MBX:
-$96.31M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OKLO vs. MBX — Risk / Return Rank
OKLO
MBX
OKLO vs. MBX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Oklo Inc. (OKLO) and MBX Biosciences, Inc (MBX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| OKLO | MBX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.00 | ||
| Sortino ratioReturn per unit of downside risk | -1.84 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.33 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | 0.23 | 4.15 | -3.92 |
| Martin ratioReturn relative to average drawdown | 0.38 | 7.99 | -7.60 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| OKLO | MBX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.16 | 1.17 | -1.00 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.51 | 0.11 | +0.40 |
Drawdowns
OKLO vs. MBX - Drawdown Comparison
The maximum OKLO drawdown since its inception was -73.83%, roughly equal to the maximum MBX drawdown of -77.71%. Use the drawdown chart below to compare losses from any high point for OKLO and MBX.
Loading charts...
Drawdown Indicators
| OKLO | MBX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -73.83% | -77.71% | +3.88% |
Max Drawdown (1Y)Largest decline over 1 year | -73.83% | -37.60% | -36.23% |
Max Drawdown (3Y)Largest decline over 3 years | -73.83% | — | — |
Current DrawdownCurrent decline from peak | -66.15% | -32.78% | -33.37% |
Average DrawdownAverage peak-to-trough decline | -17.98% | -35.04% | +17.06% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.99% | 19.50% | +25.49% |
Volatility
OKLO vs. MBX - Volatility Comparison
Oklo Inc. (OKLO) has a higher volatility of 28.53% compared to MBX Biosciences, Inc (MBX) at 23.40%. This indicates that OKLO's price experiences larger fluctuations and is considered to be riskier than MBX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| OKLO | MBX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.53% | 23.40% | +5.13% |
Volatility (6M)Calculated over the trailing 6-month period | 69.37% | 57.78% | +11.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 106.14% | 133.96% | -27.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.95% | 118.74% | -32.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 85.95% | 118.74% | -32.79% |
Dividends
OKLO vs. MBX - Dividend Comparison
Neither OKLO nor MBX has paid dividends to shareholders.
Financials
OKLO vs. MBX - Financials Comparison
This section allows you to compare key financial metrics between Oklo Inc. and MBX Biosciences, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
OKLO and MBX have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OKLO has higher volatility (28.53%) compared to MBX (23.40%). In terms of maximum drawdown, OKLO dropped -73.83% vs MBX's -77.71%.
MBX currently has the higher Sharpe Ratio (1.17 vs 0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for OKLO and MBX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer